Skip to content

Mirum Pharmaceuticals, Inc. MIRM Prepaid & Other Current

Prepaid & Other Current at other companies

Gilead Sciences logo
Gilead SciencesGILD
$4.34B+53.5%
Arrowhead Research logo
Arrowhead ResearchARWR
$21.72M-8.6%
Alkermes logo
AlkermesALKS
$102.45M+14.0%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$306.08M+37.5%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
LQD
Liquidia CorporationLQDA

Other financials

Income statement

See full
Revenue$159.9M+43.3%
Operating income-$789.5M-5,100%
Net income-$790.2M-5,284%
EPS (diluted)-$13.43-4,377%

Balance sheet

See full
Cash & equivalents$261.5M+43.5%
Total debt$13.5M+56.4%
Total equity$242.5M+4.0%
Total assets$890.9M+29.1%

Cash flow

See full
Operating cash flow-$228.8M-11,566%
CapEx$664.0K+1,520%
Free cash flow-$229.4M-11,360%

Valuation

See full
Market cap$6.53B+152%
Enterprise value$6.28B+162%
P/S11.5×+4.6×

Profitability

See full
Operating margin-139.8%-168pp
Net margin-140.2%-169pp
FCF margin-30.3%

Returns & leverage

See full
Return on equity-335.8%-377pp
Debt / equity0.1×0.0×
Current ratio2.1×-1.1×

Where this comes from

Reported directly by Mirum Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirum Pharmaceuticals, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mirum Pharmaceuticals, Inc.'s prepaid & other current?
Mirum Pharmaceuticals, Inc. (MIRM) reported prepaid & other current of $24.55M in Q1 2026.
How has Mirum Pharmaceuticals, Inc.'s prepaid & other current changed year-over-year?
Mirum Pharmaceuticals, Inc.'s prepaid & other current increased by 65.0% year-over-year, from $14.87M to $24.55M.
What is the long-term trend for Mirum Pharmaceuticals, Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s prepaid & other current has grown at a 32.0% compound annual growth rate (CAGR), from $4.53M to $18.14M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.